Statera Biopharma, Inc.
STAB
$0.0001
$0.000.00%
OTC PK
| 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | 09/30/2021 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 506.10K | 716.90K | 330.60K | 1.98M | 9.45M |
| Total Receivables | 361.40K | 414.80K | 283.60K | 348.80K | 144.20K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 97.50K | 247.00K | 499.80K | 981.90K | 2.69M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 256.60K | 298.10K | 332.60K | 845.50K | 1.05M |
| Total Current Assets | 1.22M | 1.68M | 1.45M | 4.16M | 13.33M |
|
|
|||||
| Total Current Assets | 1.22M | 1.68M | 1.45M | 4.16M | 13.33M |
| Net Property, Plant & Equipment | 1.02M | 1.25M | 1.33M | 1.17M | 959.70K |
| Long-term Investments | 9.27M | 9.27M | 9.27M | 9.27M | 76.97M |
| Goodwill | 9.27M | 9.27M | 9.27M | 9.27M | 76.97M |
| Total Other Intangibles | 1.24M | 1.35M | 1.47M | 1.58M | 1.58M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | 5.00M | 5.20M |
| Total Assets | 12.75M | 13.54M | 13.51M | 21.17M | 98.04M |
|
|
|||||
| Total Accounts Payable | 8.13M | 8.07M | 6.74M | 3.97M | 3.19M |
| Total Accrued Expenses | 6.31M | 3.61M | 1.55M | 1.75M | 1.79M |
| Short-term Debt | 6.40M | 6.40M | 5.90M | 4.58M | 3.08M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 323.60K | 364.80K | 353.40K | 255.00K | 198.30K |
| Total Finance Division Other Current Liabilities | 1.07M | 1.23M | 531.70K | 699.40K | 1.92M |
| Total Other Current Liabilities | 1.07M | 1.23M | 531.70K | 699.40K | 1.92M |
| Total Current Liabilities | 22.23M | 19.67M | 15.07M | 11.25M | 10.19M |
|
|
|||||
| Total Current Liabilities | 22.23M | 19.67M | 15.07M | 11.25M | 10.19M |
| Long-Term Debt | -- | -- | -- | 10.63M | 12.92M |
| Short-term Debt | 6.40M | 6.40M | 5.90M | 4.58M | 3.08M |
| Capital Leases | 686.10K | 793.30K | 871.30K | 806.10K | 737.40K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 22.92M | 20.46M | 15.94M | 22.68M | 23.84M |
|
|
|||||
| Common Stock & APIC | 133.78M | 133.71M | 134.78M | 127.92M | 126.38M |
| Retained Earnings | -144.08M | -140.73M | -137.24M | -129.48M | -52.26M |
| Treasury Stock & Other | 53.70K | 25.20K | -24.30K | -6.70K | -2.00K |
| Total Common Equity | -10.24M | -6.99M | -2.49M | -1.57M | 74.12M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -10.24M | -6.99M | -2.49M | -1.57M | 74.12M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 73.00K | 67.40K | 50.10K | 61.30K | 72.20K |
| Total Equity | -10.17M | -6.92M | -2.44M | -1.51M | 74.19M |
|
|
|||||